Health & Personal Care
HIGH
FDA DRUG
Dynarex Recalls Wecare Calasoothe Ointment Over cGMP Violations
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
MENTHOL AND ZINC OXIDE
cGMP deviations